InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-18.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Patel Chirag K., Co-Président. Officer active across 1 company, notably Amneal Pharmaceuticals, Inc.. Cumulatively, 5 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €367k. Activity tracked since 15 December 2021. The latest transaction was disclosed on 15 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Patel Chirag K.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
6,381,734 股Class A Common StockSEC:0001628280-26-056285:0
59,931 股Class A Common StockSEC:0001628280-26-015283:0
579,710 股Class A Common StockSEC:0001628280-25-010693:0
21,269,420 股Class A Common StockSEC:0001209191-23-054739:0
100,000 股@ US$4.13100.0% 占其流量Class A Common StockSEC:0001209191-21-070259:0
标准退出：2022年3月15日 (T+90)
5 条申报中的 5 条
About Patel Chirag K.
Chirag K. Patel is President and Co-CEO of Amneal Pharmaceuticals, Inc., a pharmaceutical company. He is responsible for the strategic direction of the company and the management of its operations. With his expertise in the pharmaceutical sector, he plays a key role in the development of new products and market expansion.
